| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.041 |
0.9 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.023 |
0.9 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
0.018 |
0.9 |
| mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |